Clinical Trials · NCT07509307

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Name: AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Amycretin

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: Novo Nordisk A/S
Enrollment: 400
Start date: Apr 2026
Locations: 81 sites, 11 countries
Primary endpoint: Relative change in body weight

View Amycretin compound reference